Ironwood Pharmaceuticals | Des Atouts



Assets Changement Date
Acadia Pharmaceuticals USD 1.19B 210.89M 2024-12
Agios Pharmaceuticals USD 1.56B 107.68M 2025-03
Almirall EUR 2.32B 14.19M 2024-06
Alnylam Pharmaceuticals USD 4.21B 26.17M 2025-03
Amarin USD 750.62M 49.24M 2024-09
Ardelyx USD 435.75M 67.89M 2024-12
Astellas Pharma JPY 3.34T 112.09B 2025-03
AstraZeneca USD 106.25B 2.22B 2025-03
Charles River Laboratories USD 7.58B 54.02M 2025-03
Exact Sciences USD 5.71B 217.07M 2025-03
Halozyme Therapeutics USD 2.2B 133.06M 2025-03
Incyte USD 5.75B 305.04M 2025-03
Ironwood Pharmaceuticals USD 351.3M 38.22M 2024-12
MacroGenics USD 261.65M 2.84M 2024-12
Moderna USD 12.7B 1.44B 2025-03
Myriad Genetics USD 1.01B 21.5M 2025-03
Pacira USD 1.55B 31.82M 2024-12
PTC Therapeutics USD 2.66B 950.36M 2025-03
Sarepta Therapeutics USD 3.47B 497.79M 2025-03
Takeda JPY 15.11T 533.85B 2024-12
Ultragenyx Pharmaceutical USD 1.31B 191.53M 2025-03



Ironwood Pharmaceuticals Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.